Vanguard Group’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $11.5M | Buy |
|
|||||
|
2022
Q2 | $13.7M | Buy |
|
|||||
|
2022
Q1 | $15.8M | Buy |
|
|||||
|
2021
Q4 | $21.5M | Sell |
|
|||||
|
2021
Q3 | $31M | Buy |
|
|||||
|
2021
Q2 | $29.1M | Sell |
|
|||||
|
2021
Q1 | $34.8M | Sell |
|
|||||
|
2020
Q4 | $25.9M | Sell |
|
|||||
|
2020
Q3 | $35.4M | Buy |
|
|||||
|
2020
Q2 | $23.1M | Sell |
|
|||||
|
2020
Q1 | $30M | Sell |
|
|||||
|
2019
Q4 | $209M | Buy |
|
|||||
|
2019
Q3 | $154M | Buy |
|
|||||
|
2019
Q2 | $154M | Buy |
|
|||||
|
2019
Q1 | $164M | Buy |
|
|||||
|
2018
Q4 | $168M | Buy |
|
|||||
|
2018
Q3 | $183M | Buy |
|
|||||
|
2018
Q2 | $147M | Sell |
|
|||||
|
2018
Q1 | $167M | Buy |
|
|||||
|
2017
Q4 | $35.1M | Buy |
|
|||||
|
2017
Q3 | $11.5M | Buy |
|